PROVIDER PROFILE · NPI 1649284308

Jack AlandM.D.

OtolaryngologyBirmingham, ALI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,057

Unique beneficiaries

—

Total services

2,907

Distinct HCPCS

Medicare payment

$58K

Peer benchmark

Total Medicare services vs. 141 Otolaryngology providers in AL — top quintile (cohort median 1,570).

PRESCRIBING · PART D · 2024

Total Rx claims

1,830

Beneficiaries

—

Total drug cost

$34K

Distinct drugs

Brand share

6.9%

Top prescribed drugs

Levocetirizine Dihydrochloride240 claims

Azelastine Hcl224 claims

Cefdinir149 claims

Ipratropium Bromide138 claims

Famotidine135 claims

QUALITY · MIPS · 2024

Final MIPS score

90.2

Quality

90.1

Cost

77.3

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.64%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$334

Payment records

By payment type

Food and Beverage$334

REFERRAL NETWORK

Where Jack Aland's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Laboratory Corporation Of America Holdings Clinical Laboratory · Birmingham, AL	71	113
UNIVERSITY OF ALABAMA AT BIRMINGHAM	61	188
COLEY, SHERRILL	47	66
NPI 1003820747	30	98
SOLSTAS LAB PARTNERS GROUP LLC	22	73
David Walters Otolaryngology · Birmingham, AL	20	50
Howard Goldberg Otolaryngology · Birmingham, AL	13	27

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history